Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
INTELLIGENT BIO SOLUTIONS INC. INBS

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Sep 2, 2026 8-K 11 signals fired
Other
Ipo Net Proceeds Disclosure Amendment Modification Waiver Clause New York Jurisdiction Clause Auditor Appointment Ratification Institutional Investment Warrant Exercise Share Delivery Material Weakness Internal Controls Reverse Stock Split Effected Warrant Valued Black Scholes Registration Rights Piggyback Provision Ipo Or Capital Raising Completion
Sep 1, 2026 8-K 3 signals fired
Other
Fda Aligned Interim Data Positive
Core
Clinical Trial Result
Aug 19, 2026 10-K 59 signals fired · top 15
Other
Audit Committee Independence Certification Material Weakness In Internal Controls Disclosed Board Diversity Policy Disclosed Code Of Conduct Adoption Disclosure Reverse Stock Split Effected Allowance For Credit Losses Methodology Disclosed Codm Segment Reporting Disclosure Net Loss Reported Depreciation Expense Composition Disclosure Deferred Tax Asset Valuation Disclosure Capital Raising Uncertainty Disclosed Interest Income Year Over Year Comparison Goodwill Impairment Clawback Policy Disclosed Ltip Plan Title Citation
Aug 19, 2026 8-K 12 signals fired
Other
Gross Margin Expanding Gross Margin Comparison Disclosed International Expansion Demand Accelerating
Healthcare
Pricing Power Services Utilization Improving Same Facility Growth
SaaS
Backlog Building Efficient Growth Recurring Revenue Growing Same Client Revenue Growing Usage Growth
Aug 11, 2026 8-K 3 signals fired
Core
Clinical Hold
Other
Enrollment Ahead Of Schedule Fda Aligned
Aug 5, 2026 8-K 1 signal fired
Other
Fda Aligned
Jul 21, 2026 8-K 2 signals fired
Other
Fda Aligned Mineral Exploration Delineation
Jun 16, 2026 8-K 9 signals fired
Core
Clinical Hold Lead Asset Progress Clinical Trial Result Indication Expansion
Other
Fda Aligned Enrollment Ahead Of Schedule Protocol Amended Interim Data Positive
Biotech Risk
Clinical Hold Active
Jun 2, 2026 8-K 1 signal fired
Core
Clinical Trial Result
May 14, 2026 8-K 15 signals fired
Other
Gross Margin Comparison Disclosed Form 8K Filing Disclosure Gross Margin Expanding Ceo Earnings Call Commentary Pricing Power Expanding Revenue Increase Attribution Disclosure
Healthcare
Pricing Power Services Utilization Improving Volume Inflecting Same Facility Growth
SaaS
Same Client Revenue Growing Efficient Growth Billings Acceleration Backlog Building Recurring Revenue Growing
May 13, 2026 10-Q 24 signals fired · top 15
Other
Material Weakness In Internal Controls Disclosed Rsu Psu Vesting Schedule Disclosed Net Loss Reported Depreciation Expense Composition Disclosure Interest Income Year Over Year Comparison Equity Compensation Accounting Policy Goodwill Impairment Reverse Stock Split Effected Allowance For Loan Losses Disclosure Credit Loss Provision Gross Profit Year Over Year Comparison Gross Margin Comparison Disclosed Shares Outstanding Disclosure Advertising Cost Disclosure Impairment Charge Breakdown
Apr 20, 2026 8-K 2 signals fired
Other
Shares Outstanding Disclosure Form 8K Filing Disclosure